Dr. Michael Joel Kane, MD

Dr. Kane practices at Backus Hospital in Norwich, Connecticut, part of Hartford HealthCare.

Dr. Kane's NPI, 1487626214, was assigned on February 6, 2006. Dr. Kane graduated from Rutgers New Jersey Medical School in 1983. Dr. Kane's Connecticut license number on file is 60331.

Dr. Kane's primary practice is Backus Hospital, at 326 Washington St, Norwich, CT 06360 in New London County. The practice phone is (860) 889-8331.

Dr. Kane's primary practice is Backus Hospital in Norwich, Connecticut, part of Hartford HealthCare. Dr. Kane is also affiliated with Windham Hospital. The medical group on file is The William W. Backus Hospital. Dmand AI also links Dr. Kane to 4 more group practices and clinics and 3 medical groups, each named with a free account. Dr. Kane's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kane practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kane's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kane is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kane's licenses on file in 4 states: Connecticut, New York, New Jersey and Pennsylvania.

Dmand AI lists chronic anemia, chronic embolism thrombosis, deep vein thrombosis (DVT), osteoporosis, purpura and thrombocytopenia, tobacco use, underactive thyroid and vitamin d deficiency among the conditions Dr. Kane treats.

CMS data shows 537 Medicare services from Dr. Kane across 5 procedure codes in 2024, for 237 Medicare patients. Medicare paid $33,555 for them.

CMS counts 237 Medicare patients who saw Dr. Kane in 2024. The largest group is 75 to 84, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kane's median patient age at 72, with 42% women.

In 2024, Dr. Kane wrote 1,051 Medicare Part D claims for 133 patients. 73% of them were for generic drugs. CMS names the drug for 900 of them, across 17 drugs with 11 or more claims each, at $3,503,043 in total drug cost. In 2023, CMS named 473 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Kane for performance year 2024, reported as part of a group. Dr. Kane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Kane in 2011. Dr. Kane's most frequent co-authors are Michael Paul Kane, MD, Mark Nathan Stein, MD and Robert S. Dipaola.

Dmand AI links Dr. Kane to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Breast Neoplasms, Colonic Neoplasms and Breast Diseases.

CMS Open Payments shows 123 general payments to Dr. Kane from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Amgen Inc. paid the most, $547.

Dmand AI lists 1 award for Dr. Kane.

Dr. Kane graduated from Rutgers New Jersey Medical School in 1983. Dr. Kane is a member of ASCO.

Dr. Kane is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.